$SNSS Recent Headlines Stocks to Watch Friday:
Post# of 44843
Posted On: 09/02/2014 9:42:48 AM
$SNSS Recent Headlines
Stocks to Watch Friday: Analogic, Werner 4:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 5:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 8:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 4:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 3:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 10:27 a.m. June 6, 2011 - Val Brickates Kennedy
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 10:13 a.m. Aug. 30, 2014 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side 8:30 a.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/12/14 12:40 a.m. Aug. 13, 2014 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% - Tale of the Tape 9:32 a.m. Aug. 6, 2014 - Zacks.com
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q2 2014 Results - Earnings Call Transcript 7:20 p.m. Aug. 5, 2014 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 4:35 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals (SNSS) Q2 2014 Results - Earnings Call Webcast 10:55 a.m. Aug. 5, 2014 - Seeking Alpha
Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog 6:45 p.m. July 14, 2014 - Zacks.com
Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session - Tale of the Tape 8:51 a.m. June 13, 2014 - Zacks.com
Sunesis Pharmaceuticals Inc Stock Downgraded (SNSS) 11:14 a.m. May 9, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
SNSS December 20th Options Begin Trading 11:02 a.m. May 8, 2014 - TheStreet.com
10-Q: SUNESIS PHARMACEUTICALS INC 4:25 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q1 2014 Results - Earnings Call Transcript 2:00 p.m. May 7, 2014 - Seeking Alpha
RSI Alert: Sunesis Pharmaceuticals (SNSS) Now Oversold 11:59 a.m. May 7, 2014 - TheStreet.com
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Ambit's Oncology Drug in Phase III - Analyst Blog 4:55 p.m. April 9, 2014 - Zacks.com
Cyclacel: Vastly Undervalued Relative To Peers 4:56 p.m. March 27, 2014 - Seeking Alpha
Sunesis Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript 3:40 p.m. March 6, 2014 - Seeking Alpha
Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape 10:25 a.m. March 5, 2014 - Zacks.com
Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference 7:01 a.m. Aug. 6, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights 7:02 a.m. Aug. 5, 2014 - GlobeNewswire
Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. July 29, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML 7:00 a.m. July 9, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wells Fargo Healthcare Conference 7:01 a.m. June 11, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASCO 2014 Annual Meeting 7:01 a.m. June 2, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 7:02 a.m. May 14, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. May 7, 2014 - GlobeNewswire
Sunesis to Host Conference Call on May 7th to Discuss First Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. April 30, 2014 - GlobeNewswire
Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014 7:01 a.m. April 22, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS 8:01 a.m. April 8, 2014 - GlobeNewswire
Sunesis Announces MD Anderson Sponsored Trial of Vosaroxin in AML and High-Risk MDS Poster to be Presented at AACR 2014 7:01 a.m. April 2, 2014 - GlobeNewswire
Appointments, Financial Reports, and FDA Approvals - Analyst Notes on Hospira, Karyopharm, Revance, Pluristem, and Sunesis 9:19 a.m. March 11, 2014 - PR Newswire - PRF
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights 8:10 a.m. March 6, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 9:19 a.m. Feb. 28, 2014 - GlobeNewswire
Sunesis to Host Conference Call on March 6th to Discuss Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights 9:18 a.m. Feb. 28, 2014 - GlobeNewswire
Sunesis Announces Pricing of a $43.0 Million Public Offering of Common Stock and Warrants 10:53 a.m. Feb. 27, 2014 - GlobeNewswire
Sunesis Announces Proposed Public Offering of Common Stock and Warrants 5:14 p.m. Feb. 26, 2014 - GlobeNewswire
Most Active Stocks Range from New Bitcoin Store to Chinese Media Company: Bitcoin Shop, Inc. (OTCQB: TUCND), Well Power, Inc. (OTCQB: VOELD), Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS, Sohu.com Inc. (NASDAQ: SOHU) 11:31 a.m. Feb. 11, 2014 - ACCESSWIRE
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data 8:01 a.m. Feb. 10, 2014 - GlobeNewswire
Stocks to Watch Friday: Analogic, Werner 4:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 5:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 8:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 4:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 3:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 10:27 a.m. June 6, 2011 - Val Brickates Kennedy
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 10:13 a.m. Aug. 30, 2014 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side 8:30 a.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/12/14 12:40 a.m. Aug. 13, 2014 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% - Tale of the Tape 9:32 a.m. Aug. 6, 2014 - Zacks.com
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q2 2014 Results - Earnings Call Transcript 7:20 p.m. Aug. 5, 2014 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 4:35 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals (SNSS) Q2 2014 Results - Earnings Call Webcast 10:55 a.m. Aug. 5, 2014 - Seeking Alpha
Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog 6:45 p.m. July 14, 2014 - Zacks.com
Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session - Tale of the Tape 8:51 a.m. June 13, 2014 - Zacks.com
Sunesis Pharmaceuticals Inc Stock Downgraded (SNSS) 11:14 a.m. May 9, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
SNSS December 20th Options Begin Trading 11:02 a.m. May 8, 2014 - TheStreet.com
10-Q: SUNESIS PHARMACEUTICALS INC 4:25 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q1 2014 Results - Earnings Call Transcript 2:00 p.m. May 7, 2014 - Seeking Alpha
RSI Alert: Sunesis Pharmaceuticals (SNSS) Now Oversold 11:59 a.m. May 7, 2014 - TheStreet.com
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Ambit's Oncology Drug in Phase III - Analyst Blog 4:55 p.m. April 9, 2014 - Zacks.com
Cyclacel: Vastly Undervalued Relative To Peers 4:56 p.m. March 27, 2014 - Seeking Alpha
Sunesis Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript 3:40 p.m. March 6, 2014 - Seeking Alpha
Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape 10:25 a.m. March 5, 2014 - Zacks.com
Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference 7:01 a.m. Aug. 6, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights 7:02 a.m. Aug. 5, 2014 - GlobeNewswire
Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. July 29, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML 7:00 a.m. July 9, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wells Fargo Healthcare Conference 7:01 a.m. June 11, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASCO 2014 Annual Meeting 7:01 a.m. June 2, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 7:02 a.m. May 14, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. May 7, 2014 - GlobeNewswire
Sunesis to Host Conference Call on May 7th to Discuss First Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. April 30, 2014 - GlobeNewswire
Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014 7:01 a.m. April 22, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS 8:01 a.m. April 8, 2014 - GlobeNewswire
Sunesis Announces MD Anderson Sponsored Trial of Vosaroxin in AML and High-Risk MDS Poster to be Presented at AACR 2014 7:01 a.m. April 2, 2014 - GlobeNewswire
Appointments, Financial Reports, and FDA Approvals - Analyst Notes on Hospira, Karyopharm, Revance, Pluristem, and Sunesis 9:19 a.m. March 11, 2014 - PR Newswire - PRF
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights 8:10 a.m. March 6, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 9:19 a.m. Feb. 28, 2014 - GlobeNewswire
Sunesis to Host Conference Call on March 6th to Discuss Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights 9:18 a.m. Feb. 28, 2014 - GlobeNewswire
Sunesis Announces Pricing of a $43.0 Million Public Offering of Common Stock and Warrants 10:53 a.m. Feb. 27, 2014 - GlobeNewswire
Sunesis Announces Proposed Public Offering of Common Stock and Warrants 5:14 p.m. Feb. 26, 2014 - GlobeNewswire
Most Active Stocks Range from New Bitcoin Store to Chinese Media Company: Bitcoin Shop, Inc. (OTCQB: TUCND), Well Power, Inc. (OTCQB: VOELD), Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS, Sohu.com Inc. (NASDAQ: SOHU) 11:31 a.m. Feb. 11, 2014 - ACCESSWIRE
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data 8:01 a.m. Feb. 10, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼